Global cardiovascular risk screening - A community pharmacy based study

被引：0
|
作者：
Martins, S. O.
Cabrita, J.
Caramona, M.
Vanmil, J.
机构：
[1] Fac Pharm, Lisbon, Portugal
[2] Fac Pharm, Coimbra, Portugal
[3] Univ Groningen, Groningen, Netherlands
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2006年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
588
引用
收藏
页码：S273 / S273
页数：1
相关论文
共 50 条
  • [21] Pharmacy- and community-based screenings for diabetes and cardiovascular conditions in high-risk individuals
    不详
    [J]. JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2006, 46 (06) : 666 - 667
  • [22] Pharmacy- and community-based screenings for diabetes and cardiovascular conditions in high-risk individuals
    Snella, Kathleen A.
    Canales, Ann E.
    Irons, Brian K.
    Sleeper-Irons, Rebecca B.
    Villarreal, Maumi C.
    Levi-Derrick, Valerie E.
    Greens, R. Shane
    Jolly, Jamie L.
    Nelson, Arthur A.
    [J]. JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2006, 46 (03) : 370 - 377
  • [23] Prevalence of silent intracerebral hemorrhages in the community-based screening studies: The cardiovascular health study and the atherosclerosis risk communities study
    Suri, MFK
    Qureshi, AI
    Kirmani, JF
    Divani, AA
    [J]. NEUROLOGY, 2005, 64 (06) : A301 - A301
  • [24] Evaluation of a Community Pharmacy-Based Screening Questionnaire to Identify Patients at Risk for Drug Therapy Problems
    Pammett, Robert T.
    Blackburn, David
    Taylor, Jeff
    Mansell, Kerry
    Kwan, Debbie
    Papoushek, Christine
    Jorgenson, Derek
    [J]. PHARMACOTHERAPY, 2015, 35 (09): : 881 - 886
  • [25] High prevalence of hypertension and cardiovascular risk score in a community based screening in Dharan (Nepal)
    Sharma, Sanjib Kumar
    Karki, Prahlad
    Nirmal, Baral
    [J]. JOURNAL OF HYPERTENSION, 2006, 24 : 78 - 78
  • [26] Cardiovascular risk reduction in the pharmacy
    Bouwer, Annatjie
    [J]. SA PHARMACEUTICAL JOURNAL, 2011, 78 (08) : 27 - 30
  • [27] Short-Term Effects of Screening for Cardiovascular Risk in the Deaf Community: A Pilot Study
    Patel, J. V.
    Gill, P. S.
    Chackathayil, J.
    Ojukwu, H.
    Stemman, P.
    Sheldon, L.
    Meelu, S.
    Lane, D. A.
    Tracey, I.
    Lip, G. Y. H.
    Hughes, E. A.
    [J]. CARDIOLOGY RESEARCH AND PRACTICE, 2011, 2011
  • [28] Physical exercise in patients with cardiovascular risk: Approximation to the situation from the Community Pharmacy
    Palo Serrano, Jose
    [J]. FARMACEUTICOS COMUNITARIOS, 2020, 12 (02): : 14 - 22
  • [29] Cardiovascular disease risk assessment among patients with hyperlipidemia at a community pharmacy setting
    Sancar, M.
    Akyildiz, E.
    Okuyan, B.
    Rabus, S. Apikoglu
    Carli, B. Soydeger
    Yilmaz, Z.
    Izzettin, F. V.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2011, 33 (02) : 429 - 430
  • [30] Strategies for detecting pharmacotherapeutic and educational needs of patients with cardiovascular risk in community pharmacy
    Buenavida Jurado, Pilar
    De la Matta Martin, Maria
    Jose Martin Calero, M.
    De la Puerta Vazquez, Rocio
    [J]. ARS PHARMACEUTICA, 2023, 64 (03) : 192 - 204
12345